
VP, Global Rare Disease Franchise
Posted 6 days ago

Posted 6 days ago
This is a fully remote position, open to applicants in United States.
• Oversee the comprehensive strategy and commercialization of REGENXBIO’s rare disease product line.
• Take ownership of the rare disease franchise's business performance and P&L, which includes revenue, profitability, forecasting, budget management, resource allocation, and commercial objectives.
• Spearhead the formulation and execution of the rare disease franchise strategy and commercialization roadmap for RGX-202 and future programs and products.
• Set business objectives, performance metrics, and operational plans.
• Manage the annual operating plan, revenue forecasts, expense budgets, and resource distribution.
• Evaluate market dynamics, competition, customer needs, and business performance to adapt strategy and investment plans accordingly.
• Collaborate with Finance and executive leadership to ensure financial rigor and accountability.
• Develop and supervise the integrated U.S. launch strategy and market entry plan for RGX-202.
• Define launch objectives, readiness milestones, performance indicators, and operational plans.
• Address challenges related to market development, patient identification and referral, treatment-center readiness, access and reimbursement, and patient onboarding.
• Oversee franchise revenue, demand generation, operational expenses, planning, forecasting, performance management, investment decisions, risks, opportunities, and sustainable growth.
• Collaborate with executive and senior leadership on global commercialization strategies and plans.
• Translate enterprise strategy into franchise priorities, operational plans, and measurable outcomes.
• Foster cross-functional alignment and accountability for commercial and franchise initiatives.
• Contribute to decisions regarding commercialization, portfolio prioritization, business development, and resource allocation.
• Represent the rare disease community in corporate strategy and decision-making processes.
• Partner with R&D on the rare neuromuscular and muscle franchise, leading cross-functional leadership and strategic planning.
• Align commercial, clinical, medical, regulatory, market access, and operational priorities.
• Utilize market, customer, patient, and competitive insights to inform pipeline strategy and development priorities.
• Provide commercial and market development insights into development plans and lifecycle strategies.
• Enhance external leadership in rare diseases through industry thought leadership, symposia, and key associations.
• Report directly to the Chief Commercial Officer.
• Lead the Rare Disease Franchise and Marketing organization.
• Advanced degree in relevant life sciences or finance (Ph.D., MBA, MS) is essential.
• Over 15 years of progressive commercial leadership experience in biotechnology or pharmaceuticals.
• Proven experience in leading substantial commercial teams and/or businesses.
• Demonstrated success in product launch leadership and/or significant accountability for launch strategy, readiness, and execution.
• Ability to effectively translate commercial and franchise strategy into clear business priorities and performance expectations.
• Strong business and financial acumen, with responsibilities including revenue, operating budgets, forecasting, resource allocation, and investment decisions.
• Experience operating effectively in highly cross-functional environments and influencing senior leaders across Commercial, Medical, R&D, Market Access, Finance, and other functions.
• Capability to build organizations and develop high-performing teams while leading through ambiguity and change.
• Willingness to travel as needed.
• Preferred: substantial rare disease commercial leadership experience.
• Preferred: experience in commercializing therapies with complex patient journeys, concentrated treatment-center models, and institutional access and reimbursement requirements.
• Preferred: familiarity with gene therapy, one-time therapies, biologics, and/or complex specialty treatment models.
• Preferred: experience contributing to lifecycle, pipeline, portfolio, or business-development decisions from a commercial perspective.
• Annual bonus program.
• Education assistance.
• Retirement plan with employer match.
• Stock options available at all levels.
• Summer hours.
• Opportunities for professional development.
• Access to development resources.
• Engaging and challenging projects.
• Competitive salary within the market.
Syner-G BioPharma Group
Allianz
Pfizer
Allianz
Get handpicked remote jobs straight to your inbox weekly.